Emad Shash

Dr. Emad Shash is a Medical Oncologist specializing in medical oncology, breast cancer care, clinical trials, and cancer education. He is the Medical Director and General Manager of the Breast Comprehensive Cancer Hospital at the National Cancer Institute, Cairo University. His work focuses on breast cancer research strategies, clinical trial design, patient education, oncology training, cancer education, and participation in global and local clinical research initiatives.

Current Position

• Medical Director and General Manager, Breast Comprehensive Cancer Hospital, National Cancer Institute, Cairo University
• General Manager, National Cancer Institute, Cairo University, June 2016–present
• President, Egyptian Gynaecological Oncology Society, December 2025–present
• Member, Board of Trustees, The National Alliance for Civil Development Work, May 2024–present
• Vice President, CAIRO Journal Club, January 2016–present
• Medical Oncologist, National Cancer Institute, Cairo University, June 2006–present
• Medical Oncology Consultant, Oncology Clinic Private Center, August 2004–present
• Medical Students and Nursing Educational Development Instructor, 2010–present

Education

• M.B.B.Ch. in Internal Medicine and Surgery, Kasr Al-Aini Medical School, 1998–2004
• Master of Science in Medical Oncology, National Cancer Institute, Cairo University, 2004–2008• Medical degree, Faculty of Medicine, Cairo University, 2004
• Specialized in Medical Oncology, National Cancer Institute, Cairo University, 2009
• Bachelor’s degree in Biology/Biological Sciences, Victoria College Maadi, 1986–1998

Professional Experience

• Medical Director and General Manager of the Breast Comprehensive Cancer Hospital, National Cancer Institute, Cairo University
• Head of the Medical Oncology Department and Breast Cancer Program Director, Shiffaa Al Orman Cancer Hospital, Luxor, Egypt, since 2016
• Visiting Medical Oncology Consultant and Chief of Medical Oncology, Shiffaa Al Orman Cancer Hospital, Luxor, since 2016
• General Manager, National Cancer Institute, Cairo University
• Leads and manages medical staff, including residents, nurses, and pharmacists, at the National Cancer Institute, Cairo University Hospitals
• Works with heads of units to support hospital functioning, communication, delegation of roles and responsibilities, and project management
• Leads implementation of specific medical objectives in the National Cancer Institute, Cairo University strategic plan
• Undertakes field visits to review quality of medical programs and progress on strategic plan objectives
• Establishes and maintains medical and research networks and collaborations
• Establishes and maintains medical and research training programs for residents, nursing staff, and pharmacists
• Associate Lecturer, National Cancer Institute, Cairo University, January 2010–January 2026
• Participated in phase II and III global clinical trials in solid and hematological malignancies, as well as local investigator-initiated clinical research projects
• Associate Editor, Journal of the Egyptian National Cancer Institute, December 2016–April 2021
• Clinical Research Physician, EORTC, Brussels, Belgium, March 2012–June 2015
• Served as the EORTC Headquarters key liaison for study coordinators and contributed to scientific input in the development, execution, analysis, and publication of EORTC clinical trials
• Coordinating research physician and medical lead for the Breast, Gynecologic Oncology, and Genito-Urinary Oncology groups at EORTC, 2011–2015
• Resident of Medical Oncology, National Cancer Institute, Cairo University, May 2006–August 2009
• Co-founder of the Egyptian Medical Sciences Foundation
• Peer reviewer and specialty editor for several international scientific journals

Research Activity

• Breast cancer research strategies
• Clinical trial design
• Phase I, II, and III clinical trials
• Breast cancer care and patient navigation
• Medical oncology
• Gynecologic oncology
• Genito-urinary oncology
• Solid malignancies
• Hematological malignancies
• Cancer education for medical students, nursing staff, and junior oncologists
• Patient education in low- and middle-income countries
• Health policy
• Oncology education and capacity building
• Clinical research in local and international settings
• Digital booking systems and workload balance in breast cancer care
• Mobile health applications among breast cancer patients and caregivers
• Oral anticancer medication adherence in breast cancer
• Homologous recombination deficiency in ovarian, peritoneal, and fallopian tube cancer
• Patient navigation and timely anti-HER2 therapy in early breast cancer

Memberships / Honors / Awards

• Excellence in Fundamentals of Clinical Trials Methodology award
• Member, European Society for Medical Oncology
• ESMO panel member
• Member, European Association of Cancer Education
• Member, American Society of Clinical Oncology
• Contributor, ASCO International Affairs Committee
• Member, Arab Medical Association against Cancer
• President, Egyptian Gynaecological Oncology Society
• Member, Board of Trustees, The National Alliance for Civil Development Work

Areas of Specialization

• Medical oncology
• Breast cancer care
• Breast cancer research strategies
• Clinical trial design
• Cancer education
• Patient education
• Gynecologic oncology
• Genito-urinary oncology
• Solid malignancies
• Hematological malignancies
• Rare cancers
• Oncology health policy
• Medical teaching
• Cancer care in low- and middle-income settings

Publications

Dr. Emad Shash has more then 90 publications.

From Misinformation to Meaningful Engagement: A Methodological Framework for Audiovisual Cancer Education in Low-Resource Settings. Journal of Cancer Education, 2026.
Non-hormonal treatments for hot flashes in breast cancer patients: a narrative review. Future Journal of Pharmaceutical Sciences, 2026.
The Effect of Losartan in Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer: A Randomized, Controlled Study. Pharmacotherapy, 2026.
Developing a practice framework for patient navigation in cancer care: a Global Initiative to Advance Cancer Navigation for Better Outcomes project. EClinicalMedicine, 2026.
Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications. BMC Cancer, 2026.
Corrigendum to Adherence to oral anticancer medications in metastatic versus nonmetastatic breast cancer patients: Insights from a low-middle-income country. Exploratory Research in Clinical and Social Pharmacy, 2026.
Medication Adherence in Breast Cancer: A Comparative Analysis of Self-Report Tools and Prescription Refill Data. Preprint, 2026.
Streamlining care through patient navigation: a retrospective cohort study of timely anti-HER2 therapy in early breast cancer in a low-middle income country. BMC Health Services Research, 2025.
Adherence to oral anticancer medications in metastatic versus nonmetastatic breast cancer patients: Insights from a low-middle-income country. Exploratory Research in Clinical and Social Pharmacy, 2025.
Impact of a public-private partnership digital booking system on workload balance in a high-volume breast cancer center: A pre-post operational study. ESMO Real World Data and Digital Oncology, 2025.
Mapping the AI readiness gap in oncology staff at a comprehensive breast cancer center: A cross-sectional survey using the MAIRS-MS scale. ESMO Real World Data and Digital Oncology, 2025.
The CAIRO Journal Club: A Decade of Impact. Journal of Cancer Education, 2025.
Guiding principles for health equity in oncology: insights from patient organizations from the Middle East and Africa. Frontiers in Health Services, 2025.
Enhancing Breast Cancer Knowledge Through an Educational Program: A Quasi-Experimental Study at Cairo University’s National Cancer Institute. JCO Global Oncology, 2025.
Evaluation of acceptance and perceived barriers to mobile health applications among breast cancer patients and caregivers in a low- to middle-income country. BMC Digital Health, 2025.
Bridging Gaps in Breast Cancer Care: A Breast Cancer Care Quality Index to Improve Outcomes Worldwide. ecancermedicalscience, 2025.
Comparative Efficacy of First-Line Chemotherapy and Endocrine Therapy in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer: A Retrospective Analysis. Egyptian Journal of Cancer and Biomedical Research, 2025.
Attitudes toward extended endocrine therapy among Egyptian women with breast cancer: A cross-sectional study. Annals of Oncology, 2025.
Marital dynamics among young married women with breast cancer: A cross-sectional study. Annals of Oncology, 2025.
Hospital time impact of subcutaneous vs intravenous anti-HER2 therapies in Egypt: A time-motion study. Annals of Oncology, 2025.
Governmental pharma-industry partnership transforms Egypt’s breast cancer patient journey: Data from the National Breast Cancer Program, 2019–2024. Annals of Oncology, 2025.
A pragmatic multi-component program enhances adherence to oral anticancer therapy in Egyptian breast cancer patients: Prospective results from the Breast Cancer Comprehensive Center. Annals of Oncology, 2025.
Public-private-NGO partnership boosts early breast cancer detection in Egypt: Lessons for scaling across LMICs. Annals of Oncology, 2025.
Arabic validation of the hot flushes diary for young breast cancer survivors: A cross cultural psychometric study. Annals of Oncology, 2025.
Epidemiologic and clinical profiles of colorectal cancer in Southern Egypt. BMC Gastroenterology, 2025.
Efficacy of a Structured Educational Program in Enhancing Breast Cancer Knowledge Among Caregivers in Egypt: A Quasi-Experimental Pilot Study. Clinical Cancer Research, 2025.
Oncologists’ Prescribing Habits for Adjuvant Therapy in Luminal Breast Cancer: Insights from a Low Middle Income Setting. Clinical Cancer Research, 2025.
Pathologic Complete Response and Residual Cancer Burden as Powerful Prognostic Markers in HER2-Positive Early Breast Cancer: A Comprehensive Real-World Study. Clinical Cancer Research, 2025.
Mapping cancer patient online support groups: enhancing patient care in a low-middle income healthcare system. Supportive Care in Cancer, 2025.
Key performance indicators of screening via clinical breast examination: A pooled analysis of 9.3 million screened women. ESMO Open, 2025.
Adjuvant radiotherapy in postmenopausal women with early-stage ER-positive breast cancer: A systematic review and meta-analysis. Medicine, 2025.
Prevalence Of Homologous Recombination Deficiency In Ovarian, Peritoneal, And Fallopian Tube Cancer In Middle East. International Journal of Gynecological Cancer, 2025.
Developing a Practice Framework for Patient Navigation in Cancer Care: A Global Initiative to Advance Cancer Navigation for Better Outcomes Project. Preprint, 2025.
Addressing the Intersection of Chemotherapy-Induced Peripheral Neuropathy and Fall Risk in Cancer Survivors: Insights and Future Directions. JCO Precision Oncology, 2024.
Evaluation of acceptance and perceived barriers to mobile health applications among breast cancer patients and caregivers at the National Cancer Institute, Cairo University. Annals of Oncology, 2024.
Evaluating adherence to oral anticancer medications in metastatic and non-metastatic breast cancer patients. Annals of Oncology, 2024.
Independent validation of the Breast Cancer Risk Assessment Tool for predicting breast cancer risk in Egyptian population. Annals of Oncology, 2024.
Impact of adjuvant hormonal therapy on sexual and global quality of life in young Egyptian women with breast cancer. Annals of Oncology, 2024.
Enhancing Patient Outcomes Through Integrated Education and Navigation Programs at the Breast Cancer Comprehensive Center, National Cancer Institute, Cairo University. Journal of Cancer Education, 2024.
Enhancing the Impact of Digital Therapeutics in Cancer Prevention: Reflections on Recent Findings. Journal of Cancer Education, 2024.
Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions. Future Journal of Pharmaceutical Sciences, 2024.
Acceptance to extend hormonal treatment among young Egyptian breast cancer patients: A questionnaire-based cross-sectional study. ESMO Open, 2024.
Clinician-Reported Outcome Measure for Palonosetron Versus Standard of Care in Chemotherapy-Induced Nausea and Vomiting in Egypt. Value in Health, 2023.
The Value of Networking in Cancer Education and Capacity Building. Journal of Cancer Education, 2023.
Clinicopathological features and outcomes of pregnancy associated breast cancer: Case control study, single institution experience. Annals of Oncology, 2023.
Guiding Towards Better Care: Breast Cancer Navigators’ Program Implementation for Increasing Patients’ Satisfaction at a Comprehensive Cancer Center. The Breast, 2023.
Quality of Life and Endometrial Cancer. Book chapter, 2022.
Egyptian gynecological oncology experience. International Journal of Gynecological Cancer, 2022.
Prevalence and Risk Factors of Burnout Among Female Oncologists From the Middle East and North Africa. Frontiers in Psychology, 2022.
General Oncology Care in Egypt. Book chapter, 2022.
Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences Consensus Recommendations 2020. Cancer Management and Research, 2022.
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. npj Breast Cancer, 2021.
Prevalence and risk factors of burnout among female oncology professionals from the Middle East and North Africa. Journal of Clinical Oncology, 2021.
Different serum, different corona! How reliable are in-vitro nanoparticle uptake experiments conducted in the presence of bovine serum? 2021.
Burnout in Oncology: Magnitude, Risk Factors, and Screening among Professionals from Middle East and North Africa. Psycho-Oncology, 2021.
Clinical correlation between Programmed Cell Death Ligand One expression, Tumor Infiltrating Lymphocytes and pathological response of locally advanced HER2 and triple negative breast cancer Egyptian patients undergoing neoadjuvant therapy. European Journal of Cancer, 2020.
Burnout among oncology professionals in the Middle East and North Africa. Annals of Oncology, 2020.
Publisher Correction: Management of Low and Intermediate Risk Adult Rhabdomyosarcoma: A Pooled Survival Analysis of 553 Patients. Scientific Reports, 2018.
Management of Low and Intermediate Risk Adult Rhabdomyosarcoma: A Pooled Survival Analysis of 553 Patients. Scientific Reports, 2018.
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma: EORTC 21081. European Journal of Dermatology, 2017.
Editor’s perspective: How rare is rare? Journal of the Egyptian National Cancer Institute, 2017.
Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma. European Journal of Cancer, 2016.
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991. Journal of Clinical Oncology, 2016.
Tenosynovial Giant Cell Tumor: Better molecular understanding revolutionizes treatment outcome. Advances in Modern Oncology Research, 2016.
The Evolution of Undergraduate Medical Student Research Activities: Personal Experience of a Developing Nation’s Uprise. Journal of Cancer Education, 2015.
Medical Student Research: An Integrated Mixed-Methods Systematic Review and Meta-Analysis. PLOS One, 2015.
LungTech, an EORTC phase II trial of Stereotactic Body Radiotherapy for centrally located lung tumours: A clinical perspective. British Journal of Radiology, 2015.
Phase I Study of the EORTC-GCG on Pazopanib with Weekly Paclitaxel and Carboplatin in Platinum-Resistant Ovarian Carcinoma. International Journal of Gynecological Cancer, 2014.
Quality of Life Research in Endometrial Cancer: What Is Needed to Advance Progress in This Disease Site? International Journal of Gynecological Cancer, 2014.
The new business model of the European Organization for Research and Treatment of Cancer. Radiotherapy and Oncology, 2014.
An example of the integrated model: the EORTC DAHANCA-1219 trial. Radiotherapy and Oncology, 2014.
Egypt. Book chapter, 2014.
New challenge of developing combined radio-drug therapy. Chinese Clinical Oncology, 2014.
Combining novel targeted therapies and radiotherapy: A challenge to overcome. Molecular Cancer Therapeutics, 2013.
The role of the European Organization for Research and Treatment of Cancer Gynecologic Cancer Group in the current European research landscape. International Journal of Gynecological Cancer, 2013.
International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective. ecancermedicalscience, 2013.
Cancer Education For Medical Students: A Developing Nation Need “2nd Year Oncology Summer School Experience.” 2012.
Cancer education for medical students in developing countries: Where do we stand and how to improve? Critical Reviews in Oncology/Hematology, 2012.
Sexuality in patients undergoing haematopoietic stem cell transplantation. International Journal of Hematology, 2011.
Fatherhood during imatinib. Acta Oncologica, 2011.
Male Breast Cancer: Clinico-Pathological Data and Impact on Survival. Annals of Oncology, 2011.
Teaching Oncology to Medical Students is a Must: The Egyptian NCI Step on the Road. Journal of Cancer Education, 2011.
Prognostic and Predictive Markers for Hepatocellular Cancer. Book, 2011.
Sunitinib Efficacy in Advanced Pancreatic Neuroendocrine Tumors. Clinical Medicine Reviews in Oncology, 2011.
Optimizing the use of epidermal growth factor receptor inhibitors in advanced non-small-lung cancer. Journal of Thoracic Disease, 2011.
GIST: the past, the present and the future. 2010.
Metastatic colorectal cancer: are we talking about curability? 2010.
Palonosetron: An Overview. 2010.

All information is sourced from publicly available materials.